BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

Heptares, Takeda deal

Heptares and Takeda entered into a two-year research agreement to research and develop compounds against GPCR to treat schizophrenia. Heptares will use its StaR technology to engineer stabilized forms of...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >